Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Thorax. 2017 Jan 27;72(5):472–474. doi: 10.1136/thoraxjnl-2016-209568

Table 1.

Associations of cholesterol and lipoproteins with HAA.

% change in HAA (95% CI)* P value
Total cholesterol −1.32 (−1.89 to −0.75) <0.001

HDL-C, mg/dL −2.12 (−2.79 to −1.44) <0.001
LDL-C, mg/dL −0.84 (−1.41 to −0.28) 0.004
Triglycerides −0.82 (−1.45 to −0.18) 0.01

Large HDL, 9.4–14 nm −1.10 (−1.93 to −0.26) 0.01
Medium HDL, 8.2–9.4 nm −2.56 (−3.31 to −1.80) <0.001
Small HDL, 7.3–8.2 nm −2.69 (−3.44 to −1.94) <0.001

Large LDL, 20.5–23 nm −1.36 (−2.06 to −0.66) <0.001
Small LDL, 18–20.5 nm −0.73 (−1.56 to 0.11) 0.09

Apolipoprotein A-1 −1.66 (−2.36 to −0.97) <0.001
Apolipoprotein B −0.69 (−1.37 to −0.01) 0.048

Solid lines separate distinct models. Each model includes all exposure variables listed and is additionally adjusted for age, gender, race/ethnicity, educational attainment, height, body mass index, waist circumference, smoking status, cigarette pack-years, glomerular filtration rate, diuretic use, statin use, presence of hypertension, presence of diabetes mellitus, coronary artery calcium, study site, milliampere dose, total volume imaged lung, percent emphysema on CT, interleukin-6 and c-reactive protein.

*

Reported per standard deviation in each exposure variable.